Bayer’s sevabertinib picks up a second-line indication for HER2-mutated disease, joining Boehringer’s zongertinib on the US ...

A recent analysis reveals that monthly prices of checkpoint inhibitors decreased only a small amount over a decade.

Patients who take omalizumab prior to starting oral immunotherapy (OIT) may skip much of the latter treatment’s onerous dose ...

Even as newer antiseizure drugs surge, global prescribing remains anchored to valproate, signaling slow adoption of safety recommendations.

Insights from ACR 2025, including anticipated presentations, key takeaways, and how emerging research in SLE may affect ...

A study suggests that lupus-like manifestations in patients with MDS/CMML frequently reflect clonal myeloid infiltration.

The Culinary Medicine curriculum is based on a national guideline, with content delivered via self-learning modules before ...

Italy’s temporary exemption rule allows foreign doctors without full recognition to work until 2027, a policy introduced ...

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

NICE has issued draft guidance recommending broader use of tranexamic acid across surgical settings to reduce bleeding, ...

A new sepsis prediction score shows a more than 75% uptake in out-of-hours primary care and is easy to use, supporting its ...

Closed-loop automated oxygen control improves respiratory outcomes in premature infants receiving mechanical ventilation ...